Navigation Links
Hundreds Literally Sea ‘sick’ on Luxury Linr

‘A sea cruise we will never forget’, is how some passengers describe it.//

They speak for many more, around 300 passengers and crew who were infected with a stomach flu-causing bug; norovirus aboard the luxury cruise ship, Queen Elizabeth 2.

This virus causes a contagious gastric illness, gastroenteritis that leaves its victims with diarrhea, stomach pain, nausea and vomiting.

The liner’s owner Cunard Line notified the Centre for Disease Control and Prevention (CDC) on January 11 that some of the passengers and crew were sick with symptoms resembling gastroenteritis caused by norovirus.

The ship was examined by CDC officials at Mexico, and docked at San Francisco.

As officials continue to perform lab tests on stool samples the suspect is norovirus, which causes this form of gastroenteritis.

Norovirus is highly contagious and infection is common this time of year. In rare cases, the elderly and young children can die from dehydration caused by norovirus symptoms. The infection, which ranks second only to the common cold in reported cases, usually clears up in two or three days with no lasting effects.

The infections amounted to nearly 17 percent of the ship's 1,652 passengers, a particularly high percentage, said Jaret Ames, acting chief of the CDC's vessel sanitation program.

By comparison, a norovirus outbreak last month aboard the world's largest cruise ship, Royal Caribbean's Freedom of the Seas, infected 338 passengers out of 3823, or less than 9 percent.

Investigators determined the emergency sanitation measures put in place by the QE2's crew, from disinfecting casino chips to halting self-service at the ship's buffet, were containing the outbreak.

Passengers report to have treated well by the crew, and many of them have recovered.

Yet this may be a sea-faring adventure whose memories they are unlikely to cherish.


AN
'"/>




Page: 1

Related medicine news :

1. Man Arrested For Sending Hundreds Of Anthrax Hoax Letters
2. Hundreds Of Jobs To Be Lost With The Merger Of Two Major Hospitals In UK
3. Hundreds of human tissue products been recalled
4. Burning fires in Northern Ontario Cause Hundreds to leave their Homes
5. Hundreds dying in northeast from AIDS
6. Hundreds of Children Put on a Trial to Trace the Cause of Peanut Allergy
7. Hundreds of Turkeys Die Due to Bird Flu
8. Luxury Spas Ride Boom in Wellness Industry in Poland
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: